{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:34:07Z","timestamp":1772825647140,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Projects in Guangzhou","award":["2023A03J0521"],"award-info":[{"award-number":["2023A03J0521"]}]},{"name":"Science and Technology Projects in Guangzhou","award":["2024A03J0563"],"award-info":[{"award-number":["2024A03J0563"]}]},{"name":"Science and Technology Projects in Guangzhou","award":["202201011789"],"award-info":[{"award-number":["202201011789"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-024-04774-y","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T02:19:37Z","timestamp":1727230777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Light-chain amyloidosis with dysphagia as the main symptom: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Maomao","family":"Ai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"issue":"2","key":"4774_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14797\/mdcvj.1070","volume":"18","author":"KR Baker","year":"2022","unstructured":"Baker KR. Light chain amyloidosis: epidemiology, staging, and prognostication. Methodist DeBakey Cardiovasc J. 2022;18(2):27\u201335. https:\/\/doi.org\/10.14797\/mdcvj.1070.","journal-title":"Methodist DeBakey Cardiovasc J"},{"issue":"2","key":"4774_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ajh.27177","volume":"99","author":"MA Gertz","year":"2023","unstructured":"Gertz MA. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment. Am J Hematol. 2023;99(2):309\u201324. https:\/\/doi.org\/10.1002\/ajh.27177.","journal-title":"Am J Hematol"},{"issue":"3","key":"4774_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.mayocp.2018.08.041","volume":"94","author":"RA Kyle","year":"2019","unstructured":"Kyle RA, Larson DR, Kurtin PJ, Kumar S, Cerhan JR, Therneau TM, Rajkumar SV, Vachon CM, Dispenzieri A. Incidence of AL amyloidosis in Olmsted County, Minnesota, 1990 through 2015. Mayo Clin Proc. 2019;94(3):465\u201371. https:\/\/doi.org\/10.1016\/j.mayocp.2018.08.041.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"4774_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000484717","volume":"4","author":"JH Hou","year":"2018","unstructured":"Hou JH, Zhu HX, Zhou ML, Le WB, Zeng CH, Liang SS, Xu F, Liang DD, Shao SJ, Liu Y, Liu ZH. Changes in the spectrum of kidney diseases: an analysis of 40,759 biopsy-proven cases from 2003 to 2014 in China. Kidney Dis. 2018;4(1):10\u20139. https:\/\/doi.org\/10.1159\/000484717.","journal-title":"Kidney Dis"},{"issue":"1","key":"4774_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000444206","volume":"2","author":"HL Nienhuis","year":"2016","unstructured":"Nienhuis HL, Bijzet J, Hazenberg BP. The prevalence and management of systemic amyloidosis in western countries. Kidney Dis. 2016;2(1):10\u20139. https:\/\/doi.org\/10.1159\/000444206.","journal-title":"Kidney Dis"},{"issue":"4","key":"4774_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/ejh.13679","volume":"107","author":"LL Hester","year":"2021","unstructured":"Hester LL, Gifkins DM, Bellew KM, Vermeulen J, Schecter JM, Strony J, Dishy V, Weiss BM. Diagnostic delay and characterization of the clinical prodrome in AL amyloidosis among 1523 US adults diagnosed between 2001 and 2019. Eur J Haematol. 2021;107(4):428\u201335. https:\/\/doi.org\/10.1111\/ejh.13679.","journal-title":"Eur J Haematol"},{"issue":"4","key":"4774_CR7","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1177\/0300060518814337","volume":"47","author":"G Li","year":"2019","unstructured":"Li G, Han D, Wei S, Wang H, Chen L. Multiorgan involvement by amyloid light chain amyloidosis. J Int Med Res. 2019;47(4):1778\u201386. https:\/\/doi.org\/10.1177\/0300060518814337.","journal-title":"J Int Med Res"},{"issue":"22","key":"4774_CR8","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3760\/cma.j.cn112137-20210302-00534","volume":"101","author":"L Zhihong","year":"2021","unstructured":"Zhihong L. Chinese Guidelines for diagnosis and treatment of systemic light-chain amyloidosis\n(revised in 2021). Natl Med J China. 2021;101(22):1646\u201356. .https:\/\/doi.org\/10.3760\/cma.j.cn112137-20210302-00534.","journal-title":"Natl Med J China"},{"key":"4774_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114129","author":"D Roccatello","year":"2020","unstructured":"Roccatello D, Fenoglio R, Sciascia S, Naretto C, Rossi D, Ferro M, Barreca A, Malavasi F, Baldovino S. CD38 and anti-CD38 monoclonal antibodies in al amyloidosis: targeting plasma cells and beyond. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21114129.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"4774_CR10","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1182\/blood-2011-10-388462","volume":"119","author":"CP Venner","year":"2012","unstructured":"Venner CP, Lane T, Foard D, Rannigan L, Gibbs SD, Pinney JH, Whelan CJ, Lachmann HJ, Gillmore JD, Hawkins PN, Wechalekar AD. Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival. Blood. 2012;119(19):4387\u201390. https:\/\/doi.org\/10.1182\/blood-2011-10-388462.","journal-title":"Blood"},{"issue":"20","key":"4774_CR11","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1182\/bloodadvances.2019000147","volume":"3","author":"E Kastritis","year":"2019","unstructured":"Kastritis E, Dialoupi I, Gavriatopoulou M, Roussou M, Kanellias N, Fotiou D, Ntanasis-Stathopoulos I, Papadopoulou E, Ziogas DC, Stamatelopoulos K, Manios E, Ntalianis A, Eleutherakis-Papaiakovou E, Papanikolaou A, Migkou M, Papanota AM, Gakiopoulou H, Psimenou E, Tselegkidi MI, Tsitsilonis O, Kostopoulos I, Terpos E, Dimopoulos MA. Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone. Blood Adv. 2019;3(20):3002\u20139. https:\/\/doi.org\/10.1182\/bloodadvances.2019000147.","journal-title":"Blood Adv"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04774-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-024-04774-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04774-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T02:20:17Z","timestamp":1727230817000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-024-04774-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4774"],"URL":"https:\/\/doi.org\/10.1186\/s13256-024-04774-y","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics requirement was waived because this manuscript is a case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"438"}}